Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12606000229572Phase 3Completed
Phase 3, randomised, double-blind trial in nicotine dependence comparing Active nortriptyline with Placebo nortriptyline (2 arms). Primary endpoints: Point prevalence abstinence, Continuous abstinence and 1 more. Started Aug 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12606000229572.